Clinical Trials Logo
  1. Home
  2. Kaposi's Sarcoma
  3. NCT02201420

Evaluation of Technetium Tc 99m Tilmanocept (Lymphoseek®) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage From KS Lesions by SPECT and SPECT/CT Imaging

Kaposi's Sarcoma Clinical Trial

Official title:
Evaluation of Technetium Tc 99m Tilmanocept Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage From KS Lesions by SPECT/CT Imaging.

Clinical Trial Summary

The purpose of this study (NAV3-12) is to determine the dissemination and localization of Tc 99m tilmanocept by SPECT and SPECT/CT imaging in subjects with confirmed cutaneous KS. This is a single center, open-label, within-subject study.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02201420
Study type Interventional
Source Navidea Biopharmaceuticals
Contact
Status Completed
Phase Phase 2
Start date September 2014
Completion date October 2015
View Details
See also
  Status Clinical Trial Phase
Terminated NCT00686842 - PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma Phase 1/Phase 2
Completed NCT00339326 - Risk Factors for Non-HIV-Related Kaposi s Sarcoma
Completed NCT01352117 - Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma Phase 3
Completed NCT01276236 - Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) Phase 2
Completed NCT00001535 - Twins Study of Gene Therapy for HIV Infection Phase 1
Completed NCT01067690 - Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma Phase 2
Completed NCT00540566 - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Completed NCT02029430 - A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma Phase 2
Completed NCT00380770 - HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT Phase 4
Completed NCT00001294 - Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens N/A
Completed NCT00055237 - Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients Phase 2
Completed NCT00026728 - Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States N/A
Terminated NCT00287495 - BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma Phase 1
Completed NCT00581815 - Spectroscopy With Surface Coils and Decoupling Phase 1
Recruiting NCT00006518 - Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Completed NCT00001560 - Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers N/A
Completed NCT00982449 - 124I-FIAU Imaging in EBV and KSHV Associated Cancers N/A
Recruiting NCT03300830 - Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Completed NCT00006171 - Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
Completed NCT00026793 - Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions